Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Success of Vertical Sleeve Gastrectomy Linked to Gut Metabolism

By HospiMedica International staff writers
Posted on 08 Apr 2014
Changes in bile acids are the key to weight-loss success and improvement in diabetes following vertical sleeve gastrectomy (VSG).

Researchers at the University of Cincinnati (UC; OH, USA), the University of Gothenburg (Sweden), and Cincinnati Children's Hospital Medical Center (OH, USA) conducted a study to examine the results of VSG surgery applied to mice with diet-induced obesity and targeted genetic disruption of the nuclear receptor farsenoid-X receptor (FXR). More...
The results of the study showed that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach, but rather increased circulating bile acids and associated changes to gut microbial communities.

The results point to bile acids and FXR signaling as an important molecular underpinning for the beneficial effects of VSG weight-loss surgery; moreover, in the absence of FXR, the ability of VSG to reduce body weight and improve glucose tolerance was substantially reduced. And because bile acids and FXR receptors interact with gut microbial communities, the researchers also looked at gut bacteria after VSG, and found that the surgery caused in changes in the gut flora. The study was publishing early online on March 26, 2014, in Nature.

“Importantly, we observed changes in several key bacterial groups that have been previously linked to the risk of Type 2 diabetes, and these changes were related to FXR and bile acids,” said lead author Prof. Karen Ryan, PhD, of the department of endocrinology, diabetes, and metabolism at UC.

“Conventional thought is when you make the stomach smaller, patients lose more weight because they have less room to put more food and, therefore, eat fewer calories,” added co-principal author Prof. Randy Seeley, PhD, director of the Cincinnati Diabetes and Obesity Center. “But as it turns out, the reason why the surgery works is that you are changing the bile acids.”

VSG is the surgical removal of a large portion of the stomach along the greater curvature, reducing it to about 25% of its original size. The procedure involves a longitudinal resection of the stomach starting from the antrum at the point 5–6 cm from the pylorus and finishing at the fundus close to the cardia; the remaining gastric sleeve is calibrated with a bougie, with the ideal approximate remaining size of the stomach after the procedure at about 150 mL. VSG is the fastest growing weight loss surgery option in North America and Asia.

Related Links:

University of Cincinnati
University of Gothenburg
Cincinnati Children's Hospital Medical Center



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.